Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Equity Average (2016 - 2025)

Historic Equity Average for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $6.8 million.

  • Apyx Medical's Equity Average fell 4817.96% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 4817.96%. This contributed to the annual value of $20.6 million for FY2024, which is 3624.82% down from last year.
  • As of Q3 2025, Apyx Medical's Equity Average stood at $6.8 million, which was down 4817.96% from $9.0 million recorded in Q2 2025.
  • Over the past 5 years, Apyx Medical's Equity Average peaked at $62.0 million during Q1 2021, and registered a low of $6.8 million during Q3 2025.
  • Over the past 5 years, Apyx Medical's median Equity Average value was $36.5 million (recorded in 2023), while the average stood at $34.2 million.
  • In the last 5 years, Apyx Medical's Equity Average tumbled by 1246.4% in 2021 and then plummeted by 6285.36% in 2024.
  • Over the past 5 years, Apyx Medical's Equity Average (Quarter) stood at $54.3 million in 2021, then decreased by 26.37% to $40.0 million in 2022, then fell by 24.37% to $30.3 million in 2023, then crashed by 57.8% to $12.8 million in 2024, then tumbled by 46.98% to $6.8 million in 2025.
  • Its Equity Average stands at $6.8 million for Q3 2025, versus $9.0 million for Q2 2025 and $12.5 million for Q1 2025.